38 More Abilify Lawsuits Claim Antipsychotic Drug Caused Impulsive Gambling Added To MDL

Print

Abilify Lawsuits Assert The Antipsychotic Medication Causes Compulsive Gambling, Eating, Sex, Shopping And Other Impulse Control Disorders.

Abilify-Juvenile-Type-2-Diabetes-LawsuitAs pretrial proceedings for Abilify Gambling lawsuits move forward, 38 new Abilify complaints have been filed in the past month. A multidistrict litigation (MDL) has been established in the U.S. District Court, Northern District of Florida for Abilify lawsuits that allege the antipsychotic medication causes impulsive gambling, shopping, eating, and other compulsive behavior disorders in people who take Abilify. Plaintiffs maintain they had no prior history of uncontrollable behaviors until they were prescribed Abilify. As a result, plaintiffs allege suffering pain, mental anguish, lost wages, significant financial problems due to gambling losses, and other injuries because of Abilify. (In Re: Abilify (Aripiprazole) Products Liability Litigation – Abilify Lawsuits MDL 2734)

According to MDL statistics from the U.S. Judicial Panel on Multidistrict Litigation, the number of Abilify lawsuits filings increased from 133 as of April 17 to 171 as of May 15. U.S. District Judge M. Casey Rodgers, who is managing the cases, said she intends to hold a hearing in July on the issue of whether Abilify causes compulsive behavior disorders since the subject is central to all the cases. Judge Rodgers intends to rule on the general causation issue by the end of summer. (In Re: Abilify (Aripiprazole) Products Liability Litigation – Abilify Lawsuits MDL 273)

“The fact that the Abilify MDL is growing shows more people are claiming to have experienced compulsive behavior disorders after being prescribed Abilify,” says Richard Schulte, co-founder of Wright & Schulte LLC.

The firm is investigating claims from men and women who allege that they developed gambling, eating, shopping, sex addictions and other impulse control problems that may be associated with Abilify. Please visit our website at www.yourlegalhelp.com or call 1-800-399-0795 to speak to one of the firms product liability attorneys.

Abilify (aripiprazole) is an atypical antipsychotic drug manufactured and marketed by Otsuka Pharmaceuticals and Bristol-Myers Squibb. Abilify is prescribed to treat schizophrenia, bipolar disorder, Tourette’s disorder, and irritability associated with autistic disorder. The medication is also used with antidepressants to treat depression. Aripiprazole is in a class of drugs called partial dopamine receptor agonists and works somewhat differently than other medicines in its class, according to the U.S. Food and Drug Administration (FDA). Most atypical antipsychotics more fully block dopamine receptors in the brain, while aripiprazole only partially blocks the activity of these receptors.
[fda.gov/Drugs/DrugSafety/ucm498662.htm]

The FDA approved Abilify in 2002 and updated the medication’s safety label last year to reflect the impulse-control risks associated with the medication. In May 2016, the FDA said it reviewed 184 cases filed with the agency since Abilify was approved in 2002. The agency found uncontrollable urges to gamble, binge eat, shop, and have sex were reported with the use of aripiprazole, which is sold under the brand names of Abilify, Abilify Maintena, Aristada, and as generics. The Abilify complaints allege
Otsuka Pharmaceuticals and Bristol-Myers Squibb knew about the compulsive behavior risks but failed to warn doctors and patients.

In addition to the FDA reports, studies have found an association between Abilify and compulsive behavior disorders. For instance, a study published in 2014 in JAMA Internal Medicine found a link between dopamine receptor agonist drugs, such as Abilify, and gambling addictions, risky sexual behavior and compulsive shopping. A 2017 study published in the Journal of Clinical Psychopharmacology also indicated a connection between Abilify and impulse control disorder and gambling disorder.
[jamanetwork.com/journals/jamainternalmedicine/fullarticle/1916909]
[journals.lww.com/psychopharmacology/Citation/2017/02000/Risk_of_Gambling_Disorder]

About Wright & Schulte LLC And Filing An Abilify Gambling Lawsuit

Wright & Schulte LLC is an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you are looking for a law firm that will guarantee the aggressive and personal representation you deserve, do not hesitate to contact Wright & Schulte LLC today. Free Abilify gambling lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Contact:
Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377
1-800-399-0795
www.yourlegalhelp.com

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.